Selected Publications

Khan N, Sundararajan R, Patel M, Trivedi C, Yang YX: Effectiveness of Tofacitinib in Patients With Ulcerative Colitis: A Nationwide Veterans Administration Cohort Study. Am J Gastroenterol Apr 2024 Notes: doi: 10.14309/ajg.0000000000002761.

Khan N, Trivedi C, Shah Y, Patel M, Sundararajan R, Xie D, Yang YX: Incidence of Pneumonia, Related Hospitalization, and Mortality Among Younger Unvaccinated IBD Patients in a Nationwide Cohort. J Clin Gastroenterol 58(3): 277-280, Mar 2024.

M C Dubinsky, M Gianfrancesco, G Gauthier, L Fallon, G R Lichtenstein, N H Khan, G Y Melmed, S Hanauer, T Ritter, G Bell, Y C Lee, N Kulisek, A Yndestad, D T Rubin: Assessment of steroid use in patients with active ulcerative colitis who initiated a new Janus kinase inhibitor or tumour necrosis factor inhibitor using data from a United States claims database. Journal of Crohn's and Colitis Jan 2024.

Sundararajan, Ramaswamy MBBS1; Patel, Manthankumar MBBS, MS1; Trivedi, Chinmay MD2; Khan, Nabeel : 5-Year Outcomes of Adalimumab Use in Nationwide Cohort of Bio-Naïve Ulcerative Colitis Patients. The American Journal of Gastroenterology Oct 2023.

Chiorean M, Ha C, Hur P, Sharma PP, Gruben D, Khan N: Experience with Tofacitinib in Patients with Ulcerative Colitis: Data from a United States Claims Database. Dig Dis Sci 68(10): 3985-399, Oct 2023.

Polson MK, Bahrain H, Ogden JF, Utkina K, Bucco RA, Khan N: Financial burden associated with discordance to intravenous iron therapies in US patients with iron deficiency anemia. J Manag Care Spec Pharm 29(7): 818-824, Jul 2023.

Khan N, Mahmud N, Patel M, Sundararajan R, Reinisch W: Risk of severe and opportunistic infections and the impact of SARS-COV-2 on this risk in a nationwide cohort of patients with inflammatory bowel disease. Aliment Pharmacol Ther 57(7): 800-80, Apr 2023.

N Khan, M Patel, R Sundararajan: Occurrence of moderate to severe anaemia and utilization and efficacy of intravenous iron therapies in a nationwide cohort of Inflammatory Bowel Disease patients. Journal of Crohn's and Colitis Feb 2023.

N Khan, N Mahmud, M Patel, R Sundararajan, W Reinisch: Incidence of Long COVID and impact of medications on the risk of developing Long COVID in a nationwide cohort of Inflammatory Bowel Disease patients. Journal of Crohn's and Colitis Feb 2023.

Khan N, Mahmud N, Patel M, Sundararajan R, Reinisch W: Incidence of Long COVID and impact of medications on the risk of developing Long COVID in a nationwide cohort of IBD patients. Clin Gastroenterol Hepatol Dec 2022.